In a parallel vein, the novel prodrug of the broad-spectrum glutamine antagonist DON is DRP-104, alias sirpiglenastat, stands out as a beacon of promise in the realm of anti-tumor agents [187]
dosing with 100 nmol kg 1 MK-801, 100 nmol kg 1 GLP-1, 100 nmol kg 1 GLP-1MK-801 or vehicle
De lenker til uavhengig hjelp og oppmuntrer til pauser
AS GLP-1s ORIGINALLY INTENDED TO TREAT TYPE 2 DIABETES (T2D) AND OFTEN DELIVERED WITH INJECTION PENS DEVELOPED FOR INSULIN ARE INCREASINGLY USED TO TREAT OBESITY, PERHAPS IT IS WORTH RETHINKING THE BASIS OF THESE DESIGNS TO ACCOMMODATE A USER GROUP THAT MAY HAVE DIFFERENT REQUIREMENTS. People with diabetes depend on these devices for survival, and the devices have been optimised accordingly for their ease of use, safety and reliability
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
